Charles Hergesheimer in San Diego, California

Additional Medical Specialties Include:
MEDICAL ONCOLOGY

Medical School: University Of California, Irvine, California College Of Medicine
Graduation Year: 1991
The Primary Medical Specialty for Charles Hergesheimer is listed as: Internal Medicine
Approximate Years of Experience: 33
PAC (PECOS ID)#: 8820139710
NPI #: 1508892860
NPI Created On: 06/25/2006
NPI Last Updated Listed as: 06/02/2021
Primary Taxonomy Code: 207R00000X
License Number:
G76058
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

Languages spoken by staff include: English, Japanese.

Services and Procedures include:

1. Destruction of skin growth
2. Aspiration and/or injection of large joint or joint capsule
3. Insertion of needle into vein for collection of blood sample
4. Vaccine for influenza for injection into muscle
5. Pneumococcal vaccine for injection into muscle
6. Routine ekg using at least 12 leads including interpretation and report
7. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
8. New patient office or other outpatient visit, typically 30 minutes
9. New patient office or other outpatient visit, typically 45 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Physician telephone patient service, 21-30 minutes of medical discussion
13. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
14. Administration of influenza virus vaccine
15. Administration of pneumococcal vaccine
16. Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem
17. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
18. Injection, denosumab, 1 mg